医药领域专利合作条约申请现状及策略

欧阳雪宇,何杰,马秋娟,闫寒,陈红霞

中国药学杂志 ›› 2014, Vol. 49 ›› Issue (14) : 1274-1280.

PDF(1510 KB)
PDF(1510 KB)
中国药学杂志 ›› 2014, Vol. 49 ›› Issue (14) : 1274-1280. DOI: 10.11669/cpj.2014.14.023
药事管理

医药领域专利合作条约申请现状及策略

  • 欧阳雪宇,何杰,马秋娟,闫寒,陈红霞
作者信息 +

Situation and Strategy of Pharmaceutical PCT Patent Applications

  • OUYANG Xue-yu, HE Jie, MA Qiu-juan, YAN Han, CHEN Hong-xia
Author information +
文章历史 +

摘要

目的 介绍专利合作条约(PCT)申请的定义和优点,分析医药领域专利合作条约申请的现状和策略。方法 以2003~2012年医药领域由中国专利局(SIPO)受理的专利合作条约申请作为研究对象,分析申请量、申请人和领域分布情况,以及进入中国专利局、欧洲专利局(EPO)、美国专利商标局(USPTO)和日本专利局(JPO)四局的审查情况。结果 2003~2012年医药领域专利合作条约申请的数量在逐年增加,其中公司是申请主力,专利合作条约申请在不同国家的审查结果不尽相同,其中中国专利局授权率最高,美国专利商标局授权率最低。结论 提出一些医药领域专利合作条约申请的可操作策略。

Abstract

OBJECTIVE To introduce the definition and advantage of PCT patent application, and to analyze the situation and strategy of pharmaceutical PCT patent applications. METHODS The quantity, applicant and field distribution of 2003~2012 pharmaceutical PCT patent applications accepted by SIPO and the examination result in SIPO, EPO, USPTO and JPO were analyzed. RESULTS The quantity of 2003~2012 pharmaceutical PCT patent applications is increased year by year. Company is the most popular applicant. The examination results of the applications are different after they entered in different countries, and the authorized rate is highest in SIPO and lowest in USPTO. CONCLUSION Operable strategies are proposed.

关键词

医药领域 / 专利合作条约申请 / 专利分析

Key words

pharmaceutical technical field / PCT application / patent analysis

引用本文

导出引用
欧阳雪宇,何杰,马秋娟,闫寒,陈红霞. 医药领域专利合作条约申请现状及策略[J]. 中国药学杂志, 2014, 49(14): 1274-1280 https://doi.org/10.11669/cpj.2014.14.023
OUYANG Xue-yu, HE Jie, MA Qiu-juan, YAN Han, CHEN Hong-xia. Situation and Strategy of Pharmaceutical PCT Patent Applications[J]. Chinese Pharmaceutical Journal, 2014, 49(14): 1274-1280 https://doi.org/10.11669/cpj.2014.14.023
中图分类号: R95   

参考文献

[1] WANG X. Introducation of the modification of the patent cooperation treaty regulations become effective in 2009.Patent Examination Review(审查业务通讯),2009,15(3):27-30.[2] TIAN L P. Basic Course of Examination of Invention-Examination.Vol14. Beijing:Intellectual Property Press(发明专利审查基础教程-审查分册),2008: 396-400.[3] YAO X F,DING J X,SHAO R.Analysis and policy recommendations of the examination of Chinese pharmaceutical patent applications.China Invention & Paten(中国发明与专利),2011,(3):47-51.[4] XUE B.China’s accession to the patent cooperation treaty . J Hebei Institute of Technology (河北理工学院学报),1994,16(3):55.[5] LIU Y.Reflections of the state-funded to Chinese main technological innovation which have obtained foreign intellectual property rights.Science & Technology Progress And Policy(科技进步与对策),2007,24(6):1-4.[6] LI L J.Analysis of the benefit to the applicant of the PCT with examples.China Invention & Paten(中国发明与专利),2012,(3):126-128.[7] LI Z J.Analysis of the situation of the PCT international paten applications.China Nonfreeous Metals(中国有色金属),2011,(4):68-69.[8] LIN J.Statistics and analysis on applications of 2011 international PCT patents.Science And Technology Management Research(科技管理研究),2013,33(2):142-145.[9] ZHANG S Z.Modification of the US patent law and the influence to China.J Law Application(法律适用),2012,(11):107-110. YIN X T.Zhongguo Zhuanlifa Xiangjie(中国专利法详解). Vol9,Beijing:Intellectual Property Press,2011:411. WANG X H.Analysis of 2006 international PCT patents. China Invention & Patent (中国发明与专利),2007,(5):87-90. Department 1 of intellectual property development research centre of SIPO. Analysis and policy recommendations of Chinese international PCT patents(part one).China Invention & Patent (中国发明与专利),2011,(1):64-66. Department 1 of intellectual property development research centre of SIPO. Analysis and policy recommendations of Chinese international PCT patents(part two).China Invention & Patent (中国发明与专利),2011,(2):59-62.
PDF(1510 KB)

Accesses

Citation

Detail

段落导航
相关文章

/